Financial Advocates Investment Management Amerisourcebergen Corp Transaction History

Financial Advocates Investment Management

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 26, 2024	BUY	N/A	44 Added 4.71%	978 $181,000
Q1 2024 May 01, 2024	BUY	N/A	934 New	934 $172,000
Q2 2023 Aug 07, 2023	SELL	$162.28 - $192.43 $19,960 - $23,668	-123 Reduced 9.56%	1,163 $223,000
Q1 2023 May 11, 2023	BUY	$148.37 - $168.96 $190,803 - $217,282	1,286 New	1,286 $205,000
Q4 2018 Feb 14, 2019	SELL	$70.76 - $93.76 $1.14 Million - $1.51 Million	-16,073 Reduced 99.64%	58 $4,000
Q3 2018 Nov 14, 2018	BUY	$78.98 - $92.22 $1.08 Million - $1.26 Million	13,658 Added 552.28%	16,131 $0
Q2 2018 Aug 09, 2018	SELL	$82.14 - $94.85 $5,256 - $6,070	-64 Reduced 2.52%	2,473 $212,000
Q1 2018 May 11, 2018	SELL	$84.01 - $105.48 $86,026 - $108,011	-1,024 Reduced 28.76%	2,537 $219,000
Q4 2017 Feb 15, 2018	BUY	$73.23 - $93.79 $260,772 - $333,986	3,561	3,561 $327,000

1,263

168M

7.52M

6.12M

Ticker ABC
Exchange NYSE
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 207,258,000
Market Cap $38.4B
Description
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to various healthcare providers, inc...

Get notified when there are updates to the investment portfolio of Financial Advocates Investment Management, based on Form 13F filings with the SEC.

Stay updated on Financial Advocates Investment Management with notifications on news.